Search all trials

Find therapies in clinical trials near you – page 52

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Complications of transplanted kidney+1

Not recruiting

Investigational

Study on ARGX-117 for Improving Kidney Function in Patients with Delayed Graft Function After Deceased Donor Transplant

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Empasiprubart

Contact Research Centre

IgA nephropathy

Not recruiting

Registered drug

Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Isis 696844

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of Forimtamig, Tocilizumab, and Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Leiomyosarcoma metastatic

Not recruiting

Registered drugNo placebo

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Filgrastim

Contact Research Centre

Essential thrombocythaemia+1

Not recruiting

Registered drugNo placebo

Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ropeginterferon Alfa-2B

Contact Research Centre

Acute lymphocytic leukaemia recurrent

Not recruiting

Registered drugNo placebo

Study of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Inotuzumab Ozogamicin

Contact Research Centre

Acute myocardial infarction

Not recruiting

Registered drug

Study to Test BI 765845 for Patients with Heart Attack

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Bi 765845

Contact Research Centre

HIV infection

Not recruiting

Registered drugNo placebo

Study on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bictegravir

Contact Research Centre

Plasma cell myeloma

Not recruiting

InvestigationalNo placebo

Study of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Hodgkin's disease

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab with Chemotherapy for Children and Young Adults with Classical Hodgkin Lymphoma Not Responding Well to Initial Treatment

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Bleomycin

Contact Research Centre

Study of Ravulizumab for Children with Thrombotic Microangiopathy After Stem Cell Transplant

Not recruiting

Registered drugNo placebo

Study of Ravulizumab for Children with Thrombotic Microangiopathy After Stem Cell Transplant

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Ravulizumab

Contact Research Centre

Myelofibrosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Aprepitant

Contact Research Centre

Find therapies in clinical trials near you – page 52

676 trials match your criteria

Complications of transplanted kidney+1

Study on ARGX-117 for Improving Kidney Function in Patients with Delayed Graft Function After Deceased Donor Transplant

IgA nephropathy

Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression

Plasma cell myeloma

Study on the Safety and Effects of Forimtamig, Tocilizumab, and Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma

Leiomyosarcoma metastatic

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Essential thrombocythaemia+1

Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Acute lymphocytic leukaemia recurrent

Study of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

Acute myocardial infarction

Study to Test BI 765845 for Patients with Heart Attack

HIV infection

Study on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression

Plasma cell myeloma

Study of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma

Hodgkin's disease

Study of Pembrolizumab with Chemotherapy for Children and Young Adults with Classical Hodgkin Lymphoma Not Responding Well to Initial Treatment

Study of Ravulizumab for Children with Thrombotic Microangiopathy After Stem Cell Transplant

Study of Ravulizumab for Children with Thrombotic Microangiopathy After Stem Cell Transplant

Myelofibrosis

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.